The global market for oral immunostimulants is set to experience a surge in value over the coming decade, with a projected CAGR of 4.1% expected to drive its worth to a valuation of USD 30 billion by 2033. With such impressive growth rates, it's no wonder that industry experts are closely monitoring this market's every move.
According to Future Market Insights, the market is expected to reach a value pool of USD 20 billion by the end of 2023, presenting a significant opportunity for pharmaceutical companies looking to tap into this lucrative and expanding sector.
| Data Points | Key Statistics |
|---|---|
| Expected Market Value in 2023 | USD 20 billion |
| Projected Market Value in 2033 | USD 30 billion |
| Growth Rate (2023 to 2033) | 4.1% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Commonly, around 10-15% of the population suffering from a compromised immune system are more exposed to infectious diseases. Oral Immunostimulant enhances the response of the immune system to fight against tumours, infectious diseases, immunodeficiency by making the specific alteration.
The rise in the immunocompromised patient population has led to the development of various oral immunostimulant.It includes a group of synthetic and biological compounds to improve defence system of human body. There have been major focus on preparation, experimental and biological characteristics of oral immunostimulant during last two decades leading to the expansion of oral immunostimulant market.
Covid-19 is projected to impact positively on an oral immunostimulant market and estimated to generate higher revenue. In the Covid-19 pandemic, an oral immunostimulant market is expected to increase product demand due to their ability to boost immunity and protect population from infections including novel coronavirus. In addition, Covid-19 pandemic has risen awareness among the population of primary role of immunity bosting products.
Risk factors such as pollution and radiation exposure has increased risk of sensitization towards various allergens. Frequent allergic reactions due to antibiotics have led to a shift of preference towards oral immunostimulant products in an oral immunostimulant market.
In addition, rising cases of infectious diseases, allergic conditions, cancer and asthma are expected to an exponential growth of oral immunostimulant market. Unavailability of any specific treatment for viral infections such as HIV/AIDS, SARS and other flu is leading the demand of oral immunostimulants.
Generic drugs and biosimilars market competition is expected to hamper the growth of oral immunostimulant market. Discontinuation of various drugs under clinical trials has led to significant revenue loss for oral immunostimulant market due to stringent regulatory policy.
Adverse effects and stringent regulatory policies are projected to be oral immunostimulant market barriers. The global oral immunostimulant market is classified based on active, indication and sales channel.
Interferon and Interleukins are collectively expected to hold major revenue share of an oral immunostimulant market. By indication, cancer segment is expected to generate highest revenue share in an oral immunostimulant market followed by chronic infections.
Among sales channel, hospital pharmacies and retail pharmacies are projected to dominate oral immunostimulant market.Oral immunostimulant market is dominated by North America owing to availability of new therapies. Europe stands second lucrative region in an oral immunostimulant market due to an increased number of research and development activities initiated in the region.
Asia Pacific region is expected to have significant growth for oral immunostimulant market owing to increased prevalence of chronic diseases in the region. The rise in healthcare expenditure in the Latin America region is projected to grow the oral immunostimulant market.
Principal Consultant
The research report on oral immunostimulant market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies. The research report on oral immunostimulant market provides analysis and information according to market segments such as drug class, route of administration, application, and region.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
5. Pricing Analysis
6. Global Market Analysis and Forecast
6.1. Active
6.2. Indication
6.3. Distribution Channels
7. Global Market Analysis and Forecast, By Active
7.1. Thymosins
7.2. Interferons
7.3. Interleukins
7.4. Glucan
7.5. Lipopolysaccharides
7.6. Levamisole
7.7. Isoprinosine
8. Global Market Analysis and Forecast, By Indication
8.1. Immunodeficiency Disorders
8.2. Chronic infections
8.3. Cancer
8.4. Organ Transplantation
9. Global Market Analysis and Forecast, By Distribution Channels
9.1. Hospital Pharmacies
9.2. Retail Pharmacies
9.3. Drug Stores
9.4. Online Pharmacies
10. Global Market Analysis and Forecast, By Region
10.1. North America
10.2. Latin America
10.3. Western Europe
10.4. Eastern Europe
10.5. Asia Pacific
10.6. East Asia
10.7. MEA
11. North America Sales Analysis and Forecast, by Key Segments and Countries
12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
15. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
16. East Asia Sales Analysis and Forecast, by Key Segments and Countries
17. MEA Sales Analysis and Forecast, by Key Segments and Countries
18. Sales Forecast by Active, Indication, and Distribution Channels for 30 Countries
19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
20. Company Profile
20.1. Step-Pharma
20.2. Novartis AG
20.3. Abbott
20.4. Amgen
20.5. Biogen
20.6. Johnson & Johnson
20.7. Merck & Co.
20.8. Eli Lilly and Company
20.9. Hoffmann-La Roche Ltd
20.10. Bristol-Myers Squibb Company
Healthcare
October 2022
REP-GB-4400
222 pages
Explore Healthcare Insights
View Reports
Oral Immunostimulant Market
